Annual FCF
-$37.25 M
-$5.26 M-16.45%
December 31, 2022
Summary
- As of February 10, 2025, NMTR annual free cash flow is -$37.25 million, with the most recent change of -$5.26 million (-16.45%) on December 31, 2022.
- During the last 3 years, NMTR annual FCF has fallen by -$19.27 million (-107.15%).
Performance
NMTR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$9.75 M
-$11.10 K-0.11%
March 31, 2023
Summary
- As of February 10, 2025, NMTR quarterly free cash flow is -$9.75 million, with the most recent change of -$11.10 thousand (-0.11%) on March 31, 2023.
- Over the past year, NMTR quarterly FCF has increased by +$1500.00 (+0.02%).
Performance
NMTR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$37.24 M
$1500.000.00%
March 31, 2023
Summary
- As of February 10, 2025, NMTR TTM free cash flow is -$37.24 million, with the most recent change of +$1500.00 (0.00%) on March 31, 2023.
- Over the past year, NMTR TTM FCF has dropped by -$1.74 million (-4.90%).
Performance
NMTR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NMTR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.4% | +0.0% | -4.9% |
| 3 y3 years | -107.2% | -270.4% | -127.5% |
| 5 y5 years | -625.3% | -39.6% | -107.2% |
NMTR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +16.5% | at low | +25.2% | +2.3% | +16.4% | +0.0% |
| 5 y | 5-year | +107.2% | at low | +270.4% | +9.4% | +127.5% | +0.0% |
| alltime | all time | +2053.0% | at low | -400.5% | +9.4% | -1248.1% | +0.0% |
9 Meters Biopharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$9.75 M(+0.1%) | -$37.24 M(-0.0%) |
| Dec 2022 | -$37.25 M(+16.5%) | -$9.74 M(-2.3%) | -$37.25 M(+5.0%) |
| Sep 2022 | - | -$9.97 M(+28.0%) | -$35.48 M(-1.9%) |
| Jun 2022 | - | -$7.79 M(-20.2%) | -$36.18 M(+1.9%) |
| Mar 2022 | - | -$9.75 M(+22.3%) | -$35.51 M(+11.0%) |
| Dec 2021 | -$31.98 M(+41.5%) | -$7.97 M(-25.3%) | -$31.98 M(+5.1%) |
| Sep 2021 | - | -$10.67 M(+50.1%) | -$30.43 M(+27.2%) |
| Jun 2021 | - | -$7.11 M(+14.1%) | -$23.92 M(-8.7%) |
| Mar 2021 | - | -$6.23 M(-2.9%) | -$26.19 M(+15.9%) |
| Dec 2020 | -$22.60 M(+25.7%) | -$6.42 M(+54.2%) | -$22.60 M(+16.5%) |
| Sep 2020 | - | -$4.16 M(-55.7%) | -$19.40 M(+0.9%) |
| Jun 2020 | - | -$9.38 M(+256.5%) | -$19.23 M(+17.4%) |
| Mar 2020 | - | -$2.63 M(-18.4%) | -$16.37 M(-8.9%) |
| Dec 2019 | -$17.98 M(+18.4%) | -$3.23 M(-19.1%) | -$17.98 M(+4.8%) |
| Sep 2019 | - | -$3.99 M(-38.9%) | -$17.16 M(+3.1%) |
| Jun 2019 | - | -$6.53 M(+54.0%) | -$16.65 M(+33.9%) |
| Mar 2019 | - | -$4.24 M(+75.9%) | -$12.44 M(-18.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$15.18 M(+195.7%) | -$2.41 M(-30.8%) | -$15.18 M(+3.0%) |
| Sep 2018 | - | -$3.48 M(+50.4%) | -$14.74 M(+19.1%) |
| Jun 2018 | - | -$2.31 M(-66.9%) | -$12.37 M(+9.6%) |
| Mar 2018 | - | -$6.98 M(+254.7%) | -$11.29 M(+119.9%) |
| Dec 2017 | -$5.14 M(-39.1%) | -$1.97 M(+77.1%) | -$5.14 M(-4.1%) |
| Sep 2017 | - | -$1.11 M(-9.8%) | -$5.36 M(-35.7%) |
| Jun 2017 | - | -$1.23 M(+49.7%) | -$8.33 M(-2.0%) |
| Mar 2017 | - | -$823.30 K(-62.4%) | -$8.50 M(+0.9%) |
| Dec 2016 | -$8.43 M(+387.1%) | -$2.19 M(-46.4%) | -$8.43 M(+6.3%) |
| Sep 2016 | - | -$4.08 M(+190.7%) | -$7.92 M(+112.9%) |
| Jun 2016 | - | -$1.41 M(+88.1%) | -$3.72 M(-34.9%) |
| Mar 2016 | - | -$747.00 K(-55.7%) | -$5.72 M(+230.7%) |
| Dec 2015 | -$1.73 M(-76.8%) | -$1.69 M(-1530.5%) | -$1.73 M(+4019.0%) |
| Sep 2015 | - | $118.00 K(-103.5%) | -$42.00 K(-73.8%) |
| Jun 2015 | - | -$3.40 M(-204.9%) | -$160.00 K(-104.9%) |
| Mar 2015 | - | $3.24 M | $3.24 M |
| Dec 2014 | -$7.45 M(+92.5%) | - | - |
| Dec 2013 | -$3.87 M | - | - |
FAQ
- What is 9 Meters Biopharma annual free cash flow?
- What is the all time high annual FCF for 9 Meters Biopharma?
- What is 9 Meters Biopharma annual FCF year-on-year change?
- What is 9 Meters Biopharma quarterly free cash flow?
- What is the all time high quarterly FCF for 9 Meters Biopharma?
- What is 9 Meters Biopharma quarterly FCF year-on-year change?
- What is 9 Meters Biopharma TTM free cash flow?
- What is the all time high TTM FCF for 9 Meters Biopharma?
- What is 9 Meters Biopharma TTM FCF year-on-year change?
What is 9 Meters Biopharma annual free cash flow?
The current annual FCF of NMTR is -$37.25 M
What is the all time high annual FCF for 9 Meters Biopharma?
9 Meters Biopharma all-time high annual free cash flow is -$1.73 M
What is 9 Meters Biopharma annual FCF year-on-year change?
Over the past year, NMTR annual free cash flow has changed by -$5.26 M (-16.45%)
What is 9 Meters Biopharma quarterly free cash flow?
The current quarterly FCF of NMTR is -$9.75 M
What is the all time high quarterly FCF for 9 Meters Biopharma?
9 Meters Biopharma all-time high quarterly free cash flow is $3.24 M
What is 9 Meters Biopharma quarterly FCF year-on-year change?
Over the past year, NMTR quarterly free cash flow has changed by +$1500.00 (+0.02%)
What is 9 Meters Biopharma TTM free cash flow?
The current TTM FCF of NMTR is -$37.24 M
What is the all time high TTM FCF for 9 Meters Biopharma?
9 Meters Biopharma all-time high TTM free cash flow is $3.24 M
What is 9 Meters Biopharma TTM FCF year-on-year change?
Over the past year, NMTR TTM free cash flow has changed by -$1.74 M (-4.90%)